ATE210149T1 - Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden - Google Patents

Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Info

Publication number
ATE210149T1
ATE210149T1 AT94919428T AT94919428T ATE210149T1 AT E210149 T1 ATE210149 T1 AT E210149T1 AT 94919428 T AT94919428 T AT 94919428T AT 94919428 T AT94919428 T AT 94919428T AT E210149 T1 ATE210149 T1 AT E210149T1
Authority
AT
Austria
Prior art keywords
dynorphine
tyr
analogues
des
inflammatory composition
Prior art date
Application number
AT94919428T
Other languages
English (en)
Inventor
Edward T Wei
Holly A Thomas
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE210149T1 publication Critical patent/ATE210149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94919428T 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden ATE210149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/074,210 US5482930A (en) 1993-06-09 1993-06-09 Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
PCT/US1994/006502 WO1994029337A1 (en) 1993-06-09 1994-06-09 Anti-inflammatory composition and method with des-tyr dynorphin and analogues

Publications (1)

Publication Number Publication Date
ATE210149T1 true ATE210149T1 (de) 2001-12-15

Family

ID=22118342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919428T ATE210149T1 (de) 1993-06-09 1994-06-09 Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden

Country Status (8)

Country Link
US (1) US5482930A (de)
EP (1) EP0751954B1 (de)
JP (1) JPH08511541A (de)
AT (1) ATE210149T1 (de)
AU (1) AU679241B2 (de)
CA (1) CA2164880A1 (de)
DE (1) DE69429365D1 (de)
WO (1) WO1994029337A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714404B1 (de) * 1993-06-18 2004-09-15 Curative Technologies, Inc. Entzündungshemmende peptide
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US6437092B1 (en) 1998-11-06 2002-08-20 Conjuchem, Inc. Conjugates of opioids and endogenous carriers
US6228840B1 (en) 1998-02-27 2001-05-08 Edward T. Wei Melanocortin receptor antagonists and modulations of melanocortin receptor activity
ES2199804T3 (es) * 1999-03-26 2004-03-01 Regeneron Pharmaceuticals, Inc. Modulacion de la permeabilidad vascular por medio de activadores del receptor tie2.
US6706892B1 (en) 1999-09-07 2004-03-16 Conjuchem, Inc. Pulmonary delivery for bioconjugation
US7652025B2 (en) * 2001-05-08 2010-01-26 Toray Industries, Inc. Remedies for sepsis
US20050143300A1 (en) * 2003-10-10 2005-06-30 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
US20050130897A1 (en) * 2003-12-11 2005-06-16 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
CA2566445C (en) 2004-05-12 2016-02-02 The Government Of The United States As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
AU2011265315B2 (en) * 2004-05-12 2014-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
NZ588895A (en) 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
JP5944316B2 (ja) 2009-10-15 2016-07-05 セラブロン セラピューティクス，インコーポレイテッド インフルエンザ処置用の組換え型ヒトｃｃ１０タンパク質
CN115583988B (zh) * 2022-10-14 2023-08-18 深圳市维琪科技股份有限公司 合成肽及其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4361553A (en) * 1981-05-18 1982-11-30 Regents Of The University Of California Therapeutic uses of dynorphin
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4684624A (en) * 1983-12-22 1987-08-04 Yoshio Hosobuchi Method of treating cerebral ischemia
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
HUT70160A (en) * 1992-06-12 1995-09-28 Des Tyr Dynorphin Partnership Process for producing des-tyr dynorphin analogues

Also Published As

Publication number Publication date
EP0751954A4 (de) 1998-06-03
JPH08511541A (ja) 1996-12-03
EP0751954B1 (de) 2001-12-05
AU679241B2 (en) 1997-06-26
CA2164880A1 (en) 1994-12-22
EP0751954A1 (de) 1997-01-08
US5482930A (en) 1996-01-09
WO1994029337A1 (en) 1994-12-22
AU7058394A (en) 1995-01-03
DE69429365D1 (de) 2002-01-17

Similar Documents

Publication Publication Date Title
ATE210149T1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
PL319608A1 (en) Compositions for treating irds and ards, containing at least one glucocorticosteroid in a mixture with a pulmonic surfactant
ITMI912296A0 (it) Nuovi pregna 1,4-diene-3,20.dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
WO2003020215A3 (en) Methods of treating mycocardial event related coditions with thymosin beta 4
FR2695714B1 (fr) Installation de traitement cryogénique, notamment de distillation d'air.
DE68917189D1 (de) Fluor enthaltendes Phosphatester, dessen Herstellung und dieses enthaltendes Rostschutzmittel.
DK0648120T3 (da) Anvendelse af phosphonater til behandling af osteoporose
CA2197544A1 (en) Fungicidal composition comprising metalaxyl and fludioxonil
AU1384995A (en) Human circulating cytokine cc-1
AU5323396A (en) Methods of treating inflammation and compositions therefor
BG104059A (en) Diabetes treatment with rosiglytazone and insulin
MX22991A (es) Agente edulcorante derivado del acido l-aspartico o l-glutamico y el procedimiento para su preparacion.
EP0161007A3 (de) Retro-inverso C-Terminal-Hexapeptid-Analoga von der Verbindung P
CA2294607A1 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
ES8403884A1 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
MY123805A (en) Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation.
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
JPS6463342A (en) Stabilization of glutathione-containing composition
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
EP0789031A3 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties